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In the initial scale-up batches of the experimental drug substance AMG 517, a pair of unexpected impurities was observed by
HPLC. Analysis of data from initial LC-MS experiments indicated the presence of two dimer-like molecules. One impurity had
an additional sulfur atom incorporated into its structure relative to the other impurity. Isolation of the impurities was performed,
and further structural elucidation experiments were conducted with high-resolution LC-MS and 2D NMR. The dimeric structures
were conﬁrmed, with one of the impurities having an unexpected C-S-C linkage. Based on the synthetic route of AMG 517,
it was unlikely that these impurities were generated during the last two steps of the process. Stress studies on the enriched
impurities were carried out to further conﬁrm the existence of the C-S-C linkage in the benzothiazole portion of AMG 517.
Further investigation revealed that these two dimeric impurities originated from existing impurities in the AMG 517 starting
material, N-acetyl benzothiazole. The characterization of these two dimeric impurities allowed for better quality control of new
batches of the N-acetyl benzothiazole starting material. As a result, subsequent batches of AMG 517 contained no reportable levels
of these two impurities
Copyright © 2009 Maria Victoria Silva Elipe et al. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
1.Introduction
In the early stages of new drug development, understanding
the impurity proﬁles of the drug substance is critical when
interpreting the data from toxicology and clinical studies.
There is a body of regulatory requirements with regard
to identiﬁcation and control of impurities. A commonly
used framework used in the pharmaceutical industry is
Q3A(R2), the International Conference on Harmonization
(ICH) guidance for controlling impurities in new drug
substance [1]. Although this guidance is intended only for
products approaching application for ﬁnal market regis-
tration, many companies consider similar elements when
evaluating impurities in new chemical entities during the
clinical phases of development.
Impurities in drug substances are classiﬁed into several
categoriesintheICHguidelineQ3A(R2):organicimpurities,
inorganic impurities, and residual solvents. The organic
impurities are of major concern for a new drug substance
producedbychemicalsynthesisbecausethepotentialtoxicity
of most of these impurities is unknown. These impu-
rities can originate from starting materials, by-products,
intermediates, degradation products, reagents, ligands, and
catalysts [1]. Knowledge of impurity structures can provide
important insight into the chemical reactions responsible for
forming these impurities as well as understanding potential
degradation pathways [2]. Such information is essential in
establishing critical control points in the drug substance
synthetic process and eventually ensuring its overall quality
and safety.
HPLC with UV detection is the most common analytical
methodology used in the pharmaceutical industry to moni-
tor organic impurities in new drug substances [2, 3]. These
HPLC-UV methods are frequently used to track impurity
proﬁles across various batches of drug substance which are
often produced by diﬀerent synthetic routes and at diﬀerent
scales. This is especially important in the earlier phases
of clinical development when, due to resources and time2 International Journal of Analytical Chemistry
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Figure 1:(a)HPLC-UVchromatogramofastandardmixtureand(b)arepresentativeAMG517samplecontainingtheunknownimpurities.
Chromatographic conditions are in the experimental section and Table 1.
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Figure 2: Synthetic pathway of AMG 517 during the early stages of clinical development.
constraints, the synthetic process is dynamic and not
completely characterized, and the source/quality of starting
materials has not been thoroughly evaluated [4]. When a
new impurity is detected above a particular threshold (e.g.,
>0.10% according to ICH Q3A(R2) for commercial prod-
ucts), structural elucidation of that impurity is typically ini-
tiated. LC-MS systems are widely available these days and are
routinelyusedininitialimpurityidentiﬁcationeﬀortsduring
e a r l yd r u gd e v e l o p m e n tp h a s e s[ 5]. The sensitivity of LC-MS
allows for the analysis of the impurities without isolation,
which is often time consuming. Coupled with knowledge
of the sample’s history (e.g., synthetic scheme, puriﬁcation
process, storage conditions, stress conditions, etc.), it is often
possible to propose the chemical structure of the impurity
solely based on LC-MS data [6, 7]. However, the LC-MS
data alone may not provide suﬃcient information to derive
a chemical structure. In such cases, NMR spectroscopy (1D
and/or 2D) is often employed to gather further structural
information for impurity identiﬁcation [8, 9]. Although
online LC-NMR has gained some popularity in recent years
[10, 11], isolation or enrichment of impurity component
for oﬄine NMR studies is still one of the most common
approaches [12, 13]. Frequently, publications detailing the
identiﬁcation of pharmaceutical impurities will focus on the
application of a selected technique and will document the
proposed formation reaction for the impurity. Rarely does
the publication involve multiple analytical disciplines used
to both identify the impurity and to trace back to its ultimate
source through a complex synthetic scheme [14].
Preparation for the ﬁrst kilogram-scale production of
one of Amgen’s investigational anti-inﬂammatory drugs,
AMG 517, provides a case in which a multidisciplinary
investigation involving HPLC-UV, LC-MS, NMR, prepar-
ative HPLC, and forced degradation was required for
unequivocal impurity identiﬁcation. Two unexpected late
eluting impurities were detected by an HPLC-UV method
during release testing of this ﬁrst scale-up batch of AMG
517 (see Figure 1). This ﬁrst kilogram-scale batch of AMG
5 1 7w a sm a n u f a c t u r e dw i t hap r o c e s st h a tw a sn o tw e l l
characterized (see Figure 2), using starting materials from
outside vendors with which we had very little prior experi-
ence. Such situation is not uncommon in early clinical drugInternational Journal of Analytical Chemistry 3
Table 1: Gradient conditions used for the HPLC-UV and LC-MS analyses of AMG 517 and N-acetyl benzothiazole.
Compound AMG 517 N-acetyl Benzothiazole
(HPLC-UV and LC-MS) (HPLC-UV) (LC-MS)
Gradient program
Time (min) %B Time (min) %B Time (min) %B
0 5 0505
15 65 10 30 10 30
20 70 15 50 15 50
27 98 20 75 20 75
30 98 25 95
Flow rate 1.0mL/min 1.5mL/min 1.0mL/min
Sample diluent 50% ACN/50% water 10% ACN/90% water
Table 2: 1Ha n d13C chemical shifts (δ/ppm) of AMG 517 standard in DMSO-d6 (400MHz).
1
2
3
4
5
6
7
N 8
9
N10
11
12
F3C 13
O
14
15
16
17
18
19
20 S 21
22 N
23
HN
24
25
3
26
O
27
CH
Position 1H( δ/ppm, J/Hz)(a) 13C( δ/ppm)(a)
1 130.9 (q, JC–F = 31.9Hz)
2, 6 7.92 (d, 2H, J = 8.2Hz)(b) 125.9 (q, JC–F = 3.7Hz)
3, 5 8.44 (d, 2H, J = 8.2Hz) 128.0
4 139.7
7 163.4
9 8.79 (s, 1H) 158.6(e)
11 170.3(d)
12 7.97 (s, 1H) 104.2
13 124.0 (q, JC–F = 272.2Hz)
15 143.5
16 7.35 (m, 1H)(c) 119.1
17 7.39 (t, 1H, J = 7.7Hz)(c) 124.2
18 7.93 (m, 1H)(b) 119.6
19 133.6
20 141.4
22 158.4(e)
24 12.42 (s, 1H)
25 169.5(d)
26 2.13 (s, 3H) 22.6
(a)Signal splitting patterns: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet; (b), (c)overlapping; (d), (e)interchangeable assignment.
development. As the new batch was slated for use in ﬁrst-
in-human clinical trials, characterization of these impurities
was required to enable process development which would
leadtobetterprocesscontrol.AsaresultofLC-MSandNMR
analyses, the structures of these impurities were proposed
as a simple dimer of AMG 517 and a thioether-linked
dimer. A typical impurity investigation may end here with
proposal of impurity structures. However, the formation of
these impurities could not be explained by the synthesis
scheme shown in Figure 2.Af o r c e dd e g r a d a t i o ns t u d yo f
the dimeric impurities provided a degree of certainty to the
proposed structure for the thioether impurity. The desire
to understand the origin of these impurities in the drug
substance led to investigation of starting materials using
HPLC-UV and LC-MS. Information compiled from these
studies allowed us to work back through the synthetic
scheme for AMG 517 to determine the source of the dimeric
impurities.Knowingtheoriginoftheseimpuritiesultimately
allowed for better quality control of the AMG 517 drug
substance.4 International Journal of Analytical Chemistry
Table 3: 1Ha n d13C chemical shifts (δ/ppm) of the enriched impurity fraction in DMSO-d6.
= R
Unknown 2 dimer R-S-R
Unknown 1 diamer R-R
1
2
3
4
5
6
7
N 8
9
N10
11
12
F3C
13
O
14
15
16
17
18
19
20 S 21
22 N
23
HN
24
25
26
O
27
3 CH
1H( δ/ppm, J/Hz)(a) 13C( δ/ppm)(a)
Position Unknown 2 Unknown 1 Unknown 2 Unknown 1
1 131.0 (q, 2JC–F = 31.7Hz) 131.0 (q, 2JC–F = 31.7Hz)
2, 6 7.92 (d, 2H, J = 8.3Hz) 7.95 (d, 2H, J = 8.3Hz) 125.9 125.9
3, 5 8.45 (d, 2H, J = 8.3Hz) 8.50 (d, 2H, J = 8.3Hz) 128.0 128.0
4 139.6 139.6
7 163.6 163.5
9 8.81 (s, 1H) 8.89 (s, 1H) 158.5 158.6(b)
11 170.1 170.2
12 8.00 (s, 1H) 8.11 (s, 1H) 104.2 104.4
13 124.0 (q, 1JC–F = 273.2Hz) 124.0 (q, 1JC–F = 273.2Hz)
15 143.7 143.5
16 7.45 (d, 1H, J = 8.2Hz) 7.59 (d, 1H, J = 8.0Hz) 120.4 119.9
17 7.49 (d, 1H, J = 8.2Hz) 7.68 (d, 1H, J = 8.0Hz) 128.1 123.9
18 122.6 131.2
19 136.6 132.8
20 141.6 141.9
22 158.5 158.4(b)
24 12.54 (s, 1H) 12.55 (s, 1H)
25 169.7 169.7
26 2.12 (s, 3H) 2.13 (s, 3H) 22.5 22.6
(a)Signal splitting pattern: s = singlet, d = doublet, q = quartet; (b)interchangeable assignments.
Table 4:Partial 1Hand13Cchemicalshifts(δ /ppm)ofthebenzothiazoleringforAMG517andtheenrichedimpurityfractioninDMSO-d6.
S
N
3
R1
2
6 1
7 1
8 1
9 1
NHR
OR
Unknown 2 R1= S-AMG 517 monomer
Unknown 1 R1= AMG 517 monomer
AMG 517 R1= H
1H( δ/ppm, J/Hz) 13C( δ/ppm)
Position AMG 517(a) Unknown 2(b) Unknown 1(b) AMG 517(a) Unknown 2(b) Unknown 1(b)
16 7.35 (m, 1H)(c) 7.45 (d, 1H, J = 8.2Hz) 7.59 (d, 1H, J = 8.0Hz) 119.1 120.4 119.9
17 7.39 (t, 1H, J = 7.7Hz)(c) 7.49 (d, 1H, J = 8.2Hz) 7.68 (d, 1H, J = 8.0Hz) 124.2 128.1 123.9
18 7.93 (m, 1H) 119.6 122.6 131.2
19 133.6 136.6 132.8
(a)Data from 400MHz NMR instrument; (b)data from 600MHz instrument; (c)overlapping signals.
2. Experimental
2.1. Materials and Reagents. HPLC grade acetonitrile (ACN,
Burdick and Jackson, Muskegon, Mich, USA), triﬂuoroacetic
acid (TFA, J. T. Baker, Phillipsburg, NJ, and Pierce,Rockford,
Ill, USA), and puriﬁed water from a Milli-Q unit (Millipore,
Molsheim, France) were used in the preparation of various
mobile phases and diluents in chromatographic analysis.
Dimethyl-d6 sulfoxide (DMSO-d6) “100%” (D, 99.96%),
used for NMR analysis, was from Cambridge Isotope Lab-
oratories (Andover, Mass, USA).
Samples of AMG 517 drug substance, N-(4-hydroxy-
benzo[d]thiazol-2-yl)acetamide (N-acetyl benzothiazole),
and the enriched impurity fraction were provided by theInternational Journal of Analytical Chemistry 5
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Figure 3: Aromatic region of the 1H NMR spectra of the enriched impurity fraction ((a) 600MHz) and AMG 517 ((b) 400MHz) in DMSO-
d6. In (a), numbers designated as prime (e.g., 3 ) represent signals of Unknown 1, with all others representing signals of Unknown 2.
170
165
160
155
150
145
140
135
130
125
120
115
110
105
100
95
f
1
(
p
p
m
)
8.98 .68 .387 .77 .4
f2 (ppm)
9  9
3 ,5   3,5
12  12
2 ,6   2,6
17 
16 
17
16
(a)
170
165
160
155
150
145
140
135
130
125
120
115
110
105
100
95
f
1
(
p
p
m
)
8.98 .68 .387 .77 .4
f2 (ppm)
9
3,5
12
2,6
18
17
16
(b)
Figure 4: Aromatic region of the 1H, 13C-2D HSQC spectrum of the enriched impurity fraction ((a) 600MHz) and the 1H, 13C-2D HMQC
spectrum of AMG 517 ((b) 400MHz) in DMSO-d6. In (a), numbers designated as prime (e.g., 3 ) represent signals of Unknown 1, with all
others representing signals of Unknown 2.
Table 5: Mass error analysis of the observed accurate mass for fragments generated by the acid hydrolysis of the enriched impurity fraction.
The analysis is conducted for both the thioether and bis-sulfoxide structures proposed for Unknown 2. (ND: not detected; N/A: not
applicable.)
Obs. mass
(M + H)+ (Da)
Calc. mass
thioether
(M + H)+ (Da)
Calc. mass
bis-sulfoxide
(M + H)+ (Da)
Mass error
thioether (ppm)
Mass error bis-
sulfoxide (ppm)
Unknown 2 891.1081 891.1060 891.1237 2.4 17.5
Mono-deacetyl 849.0967 849.0954 849.1132 1.5 19.4
Bis-deacetyl 807.0874 807.0848 807.1026 3.2 18.8
U2-669 669.0674 669.0655 669.0832 2.8 23.6
Mono-deacetyl 627.0552 627.0549 627.0727 0.5 27.9
627.0558 1.4 27.0
Bis-deacetyl 585.0458 585.0443 585.0621 2.6 27.9
U2-447 447.0250 447.0250 447.0428 0.0 39.8
Mono-deacetyl 405.0158 405.0144 405.0322 3.5 40.5
405.0157 3.2 40.7
Bis-deacetyl ND 363.0039 363.0216 N/A N/A
241 241.0579 241.0583 241.0583 1.7 1.76 International Journal of Analytical Chemistry
Table 6: Summary of proposed structures of impurities observed in the LC-MS analysis of N-acetyl benzothiazole.
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MS447
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MS405
Deacetylated MS447 
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Figure 5: UV chromatogram from the LC-MS analysis of the
acid hydrolyzed impurities. Labeled peaks correspond to hydrolysis
fragments of Unknown 1 (U1) and Unknown 2 (U2).
ChemicalProcessResearchand Development Departmentof
Amgen inc., (Thousand Oaks, Calif, USA).
2.2. HPLC. Analytical-scale chromatographic analyses were
performedonanAgilent(Wilmington,Del,USA)1100series
HPLC system. Mobile phase A was 0.1% TFA in water;
mobile phase B was 0.1% TFA in ACN. A Phenomenex
(Torrance, Calif, USA) Luna C18(2) HPLC column (5μm,
150 × 4.6mm, at 30
◦C) was used for the separation and
quantitation of the AMG 517 impurities. Two diﬀerent
gradients with diﬀerent ﬂow rates were employed for the
separation of AMG 517 and N-acetyl benzothiazole (see
Table 1). A UV detection wavelength of 254nm and an
injection volume of 30μL were used in the analysis of both
compounds.
2.3. LC-MS. LC-MS experiments with accurate mass deter-
mination via high resolution mass spectrometry were per-
formed using an Agilent 1100 HPLC (conﬁgured with a
diode array UV detector) interfaced with a Waters (Milford,
Mass, USA) Micromass Q-Tof Ultima API quadrupole time-
of-ﬂight mass spectrometer. The mass spectrometer was
conﬁgured with a lockspray electrospray ionization (ESI)
source to allow for the introduction of an internal mass
calibration solution, which provides for a 5ppm mass error
speciﬁcation when used in conjunction with tune settings
producing ∼20000 mass resolution on the instrument.
LC-MS analyses of the enriched impurities, and of their
hydrolysates, were accomplished using a Phenomenex Luna
C18(2) HPLC column (3μ, 100 ˚ A, 2.0×150mm) and mobile
phase consisting of 0.1% aqueous TFA (mobile phase A)International Journal of Analytical Chemistry 7
N N
O S
N
O
S
N
N
O
S
N
O
N
N
O
S
N
O
S N
S O
N
N
O
S
N
O
O
N
S
O
N
N
O
O
S
N
O
O
N
S
O
N
N
O
O
S
N
O
S
HN
N
S O
S
N
O
O
N
S O
O
N
N
+
+
+
241
HCL
OH
OH OH
OH
HO HO
HO
HN
HN
HN
HN
F3C
F3C
3 CF
3 CF
3 CF
NH
NH
NH
NH
NH NH
NH
F3C
3 CF Unknown 2 (thioether) Unknown 2 (bis-sulfoxide)
Δ
Deacetylated Unknown 2(U2-849andU2-807)
U2-447&
deacetylated U2-447(U2-405andU2-363)
U2-669&
deacetylated U2-669(U2-627andU2-585)
Figure 6:PotentialfragmentsproducedbyacidhydrolysisofUnknown2.Structuresontheleftrepresentfragmentsexpectedtobegenerated
from the thioether, those on the right from the bis-sulfoxide. Fragment 241 would be common to both structures.
and 0.1% TFA in ACN (mobile phase B). A ﬂow rate
of 0.2mL/minute was used, and a column temperature of
30
◦C was maintained throughout each HPLC run. Gradient
conditions listed in Table 1 for the HPLC-UV analysis of
AMG 517 were also used for the LC-MS analysis of AMG 517
and its impurities.
LC-MS analysis of the AMG 517 starting material, N-
acetyl benzothiazole, was accomplished using a Phenomenex
Luna C18(2) HPLC column (3μ, 100 ˚ A, 4.6 × 150mm).
The same mobile phase system described above was used
at a ﬂow rate of 1.0mL/minute. Column temperature was
also maintained at 30
◦C. The gradient conditions used for
the LC-MS analysis of N-acetyl benzothiazole are listed in
Table 1.
2.4. NMR. Spectra were acquired at 25
◦Ca n d2 7
◦Co n
Bruker DPX 400 and Bruker AVANCE 600 NMR instru-
ments (Bruker BioSpin Corporation, Billerica, Mass, USA)
equipped with 5mm and 2.5mm multinuclear inverse z-
gradient probes, respectively. 1HN M Re x p e r i m e n t sw e r e8 International Journal of Analytical Chemistry
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Figure 7: Expanded view of the UV chromatogram from the LC-
MS analysis of N-acetyl benzothiazole lot A (ca. 0.1mg/mL in 10%
ACN, 3μg injected on column).
carried out at 400.13 and 600.13MHz, respectively, and
13C NMR experiments were carried out at 100.61 and
150.90MHz, respectively. The data processing was per-
formed on the spectrometers. Chemical shifts are reported
in the δ scale (ppm) by assigning the residual solvent
peak at 2.50 and 39.51ppm to DMSO for 1Ha n d13C,
respectively. The 1D 1Ha n d13C NMR spectra were
determined using a 30
◦ ﬂip angle with 1 second and 2
seconds equilibrium delays, respectively. The 90
◦ pulses
used were 7.7 and 4.5 microseconds for 1H, and 22.0 and
12.50 microseconds for 13C in experiments carried out
on the 400 and 600MHz spectrometers, respectively. The
1H, 1H-2D correlation spectroscopy (COSY) spectra were
acquired into 2K data points in the f2 dimension with
128 increments in the f 1 dimension, using a spectral width
of 4789.3Hz on the 400MHz spectrometer and 7788.2Hz
on the 600MHz instrument. The nuclear Overhauser eﬀect
spectroscopy (NOESY) experiments were determined with
an 800 milliseconds mixing time, and with the same spectral
width for f2 dimensions as COSY experiments, but with 256
increments in f1 dimension. The delays between successive
pulses were 1.5 and 2 seconds for 2D COSY and NOESY,
respectively. Both the 1H, 13C-2D heteronuclear single-
quantum correlation (HSQC) and 1H, 13C-2D heteronuclear
multiple bond correlation (HMBC) spectra were determined
using gradient pulses for coherence selection. The 1H, 13C-
2D heteronuclear multiple-quantum correlation (HMQC)
and the HSQC spectra were determined with decoupling
during acquisition. The 2D HMQC and 2D HMBC exper-
imental data were acquired on the 400MHz spectrometer
with spectral widths of 4789.3Hz for 1H and 20123.9Hz
for 13C, into 1K data points in the f2 dimension with
128 increments in the f1 dimension. The 2D HSQC and
2D HMBC experimental data carried out on the 600MHz
spectrometer were acquired with spectral widths of 6009.6
and 7788.2Hz for 1H for HSQC and HMBC, respectively,
and 27162.5Hz for 13C dimension. The data were acquired
into 1K and 4K data points in the f2 dimension for HSQC
and HMBC, respectively, and with 256 and 128 increments
in the f 1 dimension for HSQC and HMBC, respectively.
Delays corresponding to one bond 13C–1H coupling (ca.
145Hz) for the low-pass ﬁlter and to two-to-three bond
13C–1H long range coupling (7.7Hz) were used for the
HMBC experiments. All 2D NMR data were processed using
sine and qsine weighting window functions with some line
broadening.
3. Results and Discussion
3.1. Impurity Proﬁles in Kilogram-Scale Batches of AMG 517
Drug Substance. A stability indicating HPLC-UV method
was developed to separate and quantify AMG 517 along with
its potential impurities and possible degradants. Figure 1(a)
representsatypicalseparationofastandardmixtureofAMG
517 in the presence of its known impurities and degradants.
This method was used to analyze the ﬁrst six drug substance
batches of AMG 517 during release and stability testing
of these lots. A pair of unexpected late-eluting unknown
impurities was observed in all six batches of AMG 517. The
area percent levels of impurity Unknown 1 ranged from
0.15% to 0.44%, while Unknown 2 ranged from 0.06%
to 0.21%. A representative chromatogram of an AMG 517
drug substance lot containing these impurities is shown in
Figure 1(b). These two impurities were not detected at a
reportable level in the previous small-scale batches of AMG
517. Since these two unknown impurities eluted near the
retention time of the by-product in step 1 of the AMG
517 synthetic reaction, it was concluded that these new
impurities were highly hydrophobic and may have structural
features similar to the by-product (see Figure 2).
Preliminary low-resolution LC-MS analysis on the drug
substance provided molecular mass and tandem mass spec-
trometry (MS/MS) fragment ion information for these two
impurities (data not shown). The observed mass for the
protonated Unknown 1 and Unknown 2 was 859Da and
891Da, respectively. Since the exact mass for AMG 517
is 430.0711Da, an observed mass of 859Da for Unknown
1 suggested that it could be some sort of dimeric struc-
ture related to AMG 517. MS/MS data also suggested
dimeric structures for both impurities. Fragment ions that
corresponded to the neutral loss of multiple acetyl and
hydroﬂuoric functional groups were observed in MS/MS
experiments performed on the protonated ions of both
Unknown 1 and Unknown 2. The mass diﬀerence between
the two unknowns was 32Da, which could be attributed to
either one additional sulfur atom or two additional oxygen
atoms in Unknown 2 relative to Unknown 1. However, the
preliminary LC-MS analysis alone could not conclusively
identify the structures of these impurities due to the possible
existence of multiple isomeric structures consistent with
the mass data. To aid in the structural elucidation eﬀorts,
an enriched fraction of these two impurities was isolated
via preparative-scale HPLC. The isolated fraction containedInternational Journal of Analytical Chemistry 9
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Figure 8: (a) MS/MS analysis (with accurate mass determination) of the protonated ion of MS447. (b) Schematic of the MS/MS
fragmentation interpretation of MS447.
about 35% of Unknown 1 and 62% of Unknown 2 based on
UVdetectionat254nm.LC-MSandNMRexperimentswere
performed to characterize this enriched fraction.
3.2. Accurate Mass Determination for Unknowns 1 and 2
in the Enriched Fraction. An accurate mass of 859.1342Da
was determined for Unknown 1 in the enriched fraction.
Elemental composition analysis was performed for this
protonated mass. Instrument performance, the synthetic
pathway for AMG 517, and information gained from the
preliminary LC-MS analysis of the impurities were taken
into account in setting parameters for this analysis. Based
upon the performance of the mass spectrometer, the error
between the observed and calculated masses was limited to
5ppm or less. MS/MS analysis indicated the presence of
two triﬂuoromethyl groups, so the number of atoms of F
required was set to six. MS/MS analysis also indicated the
presence of two acetyl groups, so the minimum number of
atoms of O required was set to two. Consideration of the
synthetic pathway for AMG 517 suggested that a molecule
containing less than four atoms of N was unlikely. All
elemental composition analyses performed as part of this
investigation utilized a similar strategy to logically identify
the most likely elemental formula for an observed mass.
The elemental composition analysis for the observed
mass of Unknown 1 determined that the elemental formula
C40H24N8O4F6S2 was the best ﬁt for the impurity. This ele-
mentalcompositionwasconsistentwithadimerofAMG517
minus two hydrogens (elemental formula C20H13N4O2F3S).
The mass error between the observed mass for Unknown
1 and the calculated mass for a dimer of AMG 517 was
0.3ppm.
An accurate mass of 891.1058Da was determined for
Unknown 2 in the enriched fraction. Elemental composition
analysis using this protonated mass determined that the
elemental formula C40H24N8O4F6S3 was the best ﬁt for the
impurity. This elemental composition was consistent with
a dimer of AMG 517 with the addition of a sulfur atom
[dimer+S]. The mass error between the observed mass for
Unknown 2 and the calculated mass for [dimer+S] was
0.8ppm.
Another possible elemental formula for Unknown 2 is
C40H24N8O6F6S2 which corresponded to an AMG 517 dimer
with two additional oxygen atoms [dimer+2O]. The mass
error between the observed mass for Unknown 2 and the
calculated mass for the [dimer+2O] was 20.7ppm. Based on
the accurate mass data, it was concluded that [dimer+S] was
a more likely structure for Unknown 2.
The MS data was consistent with dimeric structures for
both Unknown 1 and Unknown 2 but provided no deﬁnitive
structural linkage information. The structure of AMG 517
itself and the synthetic scheme shown in Figure 2 did not
provide any obvious possible point of linkage. Therefore,
NMR analyses were performed on the enriched fraction to
help elucidating the structures of these impurities.
3.3. NMR. AMG 517 and its enriched impurity fraction
containing Unknowns 1 and 2 were ﬁrst analyzed by 1H
and 13C NMR to further investigate the connectivity. Proton
assignments were made based on chemical shifts, proton-
proton coupling constants, and COSY and NOESY spectra
(see Tables 2 and 3). Carbon assignments were based on
chemical shifts, carbon-ﬂuorine coupling constants, and
HMQC, HSQC, and HMBC spectra (see Tables 2 and 3).
All assignments referring to the structures of AMG 517 and
impurities are depicted in these two tables.
NMR analysis was also conducted on AMG 517 for
comparison (see Table 2). The 1H NMR spectrum showed10 International Journal of Analytical Chemistry
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Figure 9: Proposed structures and formation pathway for the two unknown impurities in AMG 517.
the presence of all the protons of the molecule including the
exchangeable NH proton. The 1H NMR spectrum showed
the presence of three aromatic systems, an AA’BB’ spin
system (δ 7.92 and 8.44ppm) for a p-disubstituted benzene
ring,twosinglets(δ 7.97and8.79ppm)foranotheraromatic
ring,andanABXspinsystem(δ 7.35,7.39,and7.93ppm)for
a 1,2,3-trisubstituted benzene ring. The downﬁeld chemical
shift of the singlet at 8.79ppm together with the singlet at
7.97ppm suggested a 4,6-disubstituted pyrimidine as one of
the aromatic rings in the molecule. The 13CN M Rs p e c t r u m
showedthepresenceofallthecarbonsofthemolecule.Three
of these carbons were coupled to 19F; C-13 as a quartet
through one C–F bond (δ 124.0, 1J[13C, 19F] = 272.2Hz), C-
1 as a quartet through one C–C and one C–F bonds (δ 130.9,
2J[13C, 19F] = 31.9Hz), and C-2, 6 as a quartet through two
C–C and one C–F bonds (δ 125.9, 3J[13C, 19F] = 3.7Hz) (see
Table 2).
The 1H NMR spectrum of the enriched fraction con-
taining the impurities indicated that the sample was a
mixture of two components structurally related to AMG
517, present at a ratio of 1:1.94 based on the areas of
their related aromatic signals. Based on the HPLC-UV data
from the enriched fraction, the major component present
corresponded to Unknown 2, and the minor component
to Unknown 1. The 1H NMR spectrum of the impurities
contained signals corresponding to the same substitution
patterns observed for AMG 517 (see Figure 3). 1HN M Ra n d
1H, 1H-2D NOESY spectra indicated the presence of a p-
disubstituted benzene ring, a 4,6-disubstituted pyrimidine,
a 2,4,7-trisubstituted benzothiazole ring, and an N-acetyl
group. The only diﬀerence between AMG 517 and these
two related compounds is the substitution pattern of the
benzothiazole. The 1H NMR spectrum showed more distinct
chemical shift diﬀerences for the protons H-16 and H-
17 from these two AMG 517-related compounds (see
Figure 3 and Table 4). The signals from Unknown 1 were
shifted downﬁeld compared to Unknown 2. The elemental
molecular formulae for Unknowns 1 and 2 were indicative of
dimer structures. Only one set of resonances was observed
for each of the two unknowns. This indicated that theInternational Journal of Analytical Chemistry 11
unknowns were symmetrical dimers. The monomers were
connected through carbon C-18 based on the presence of an
AB system, their chemical shifts, and the coupling constants
for the benzothiazole ring. The 1H, 13C-2D HSQC spectrum
supported the 1H NMR data showing only two aromatic C–
H (C-16 and 17) on the benzothiazole ring of the impurities.
The absence of a C–H signal for C-18, as was observed in
AMG 517, was noted in the NMR spectra in both of the
unknowns (see Figure 4). 13CN M R ,1H, 13C-2D HSQC,
and 1H, 13C-2D HMBC spectra of the impurities showed
more distinct chemical shift diﬀerences for the carbons C-
16, C-17, C-18, and C-19. This indicated that the diﬀerence
between these two impurities was in the linkage through C-
18, either directly or through a heteroatom (see Table 4).
The possibility of having a sulfur atom connecting the two
AMG 517 monomers for Unknown 2 was considered very
plausible based on the MS data and the chemical shift data
(see Table 4).
3.4. LC-MS Analysis of the Hydrolysate of the Enriched
Impurities. The MS data for the two impurities strongly
supported a thioether-linked dimer of AMG 517 as the
structure for Unknown 2. The 1Ha n d13CN M Rd a t a
provided indirect evidence of such thioether linkage but
could not aﬀord direct measurement of the heteroatom.
However, the formation of this impurity in the synthesis
of AMG 517 (see Figure 2) did not seem as plausible as
the oxidation of a heteroatom from a reaction mechanistic
standpoint. There was a signiﬁcant diﬀerence between the
calculated mass values for the two potential structures
for Unknown 2, however, the relatively high mass of the
impurity resulted in a large number of potential elemental
formulae. To simplify the elemental composition analysis,
a chemical degradation experiment was performed. The
enriched fraction was treated with 0.5 equivalent of aqueous
HCl in DMSO-d6 a n dh e a t e do v e r n i g h ta t7 0
◦C. This
experiment furnished low-molecular-weight fragments of
the impurity that could not be generated via MS/MS. These
low-mass fragments resulted in a small number of potential
elemental formulae for each observed mass.
Multiple hydrolysis fragments were observed in LC-
MS after forced degradation of the enriched fraction with
hydrochloric acid (see Figure 5). Accurate mass data col-
lected in the LC-MS analysis of the acid treated enriched
impurity fraction was used to identify peaks corresponding
to the expected hydrolysis fragments (see Figure 5). The
scheme in Figure 6 shows the expected acid hydrolysis
fragments from Unknown 2, with Unknown 2 and its frag-
ments presented using both the thioether and bis-sulfoxide
structures being considered for the impurity. A number
of deacetylation products were also observed. This LC-MS
analysis demonstrated that all of the expected fragments for
Unknown 2 (and some for Unknown 1) were formed during
the forced degradation.
Table 5 shows the accurate mass assignments for the acid
hydrolysis products of Unknown 2 as well as the calculated
exact mass for each product that was expected to arise from
both the proposed thioether and bis-sulfoxide structures.
The mass error (observed mass versus calculated mass of the
hydrolysis fragments) is shown for each proposed structure
forUnknown2.Themasserrorrangeforhydrolysisproducts
arising from the thioether structure was 0 to 3.5ppm; the
mass error range for the corresponding bis-sulfoxide was
17.5 to 40.7ppm. Thus, the accurate mass data collected for
the acid hydrolysis fragments allowed for elimination of the
bis-sulfoxide as a potential structure for Unknown 2.
These mass error results strongly supported an elemen-
tal formula of C40H24F6N8O4S3 (thioether) for Unknown
2, and essentially ruled out an elemental formula of
C40H24F6N8O6S2 (bis-sulfoxide) for the impurity.
3.5. LC-MS Analysis of N-Acetyl Benzothiazole Starting
Material. Although the MS and NMR data provided great
conﬁdence in the proposed dimeric structures for these two
late-eluting impurities, the chemical reactions described in
Figure 2 were not likely to generate such impurities. Since
the dimeric linkages are in the benzothiazole portion of
AMG 517, it was possible that these two impurities were
originated from existing impurities in the AMG 517 starting
material, N-acetyl benzothiazole, which was prepared via
multistep synthesis from 2-methoxybenzenamine by a con-
tract manufacturer. To determine if N-acetyl benzothiazole
was a potential source for generating Unknowns 1 and
2, additional experiments were performed to evaluate the
impurity proﬁles of N-acetyl benzothiazole.
Ad i ﬀerent HPLC method was developed for the anal-
ysis of N-acetyl benzothiazole (see Table 1). Although the
supplier’s Certiﬁcate of Analysis indicated an HPLC purity
of >99% area for various batches of N-acetyl benzothiazole,
retrospective analysis by Amgen’s HPLC method resulted in
purities ranging from 96.2 to 98.2% area. LC-MS analysis
was performed on lot A, the starting material used in the
productionofthesixkilogram-scaleAMG517batches.Anal-
ysis of this lot indicated that there were multiple impurities,
some of which had the potential to generate Unknowns 1
and 2 (see Figure 7). These impurities were designated by
their nominal mass values as determined by the LC-MS
analysis (e.g., MS447 corresponds to a compound with an
observedmassof447Da).Table 6 providesa summaryof the
proposed structures for the observed impurities of N-acetyl
benzothiazole.
An accurate mass of 447.0247Da was determined for
the protonated ion of impurity MS447 in N-acetyl benzoth-
iazole. Elemental composition analysis using the observed
mass determined that the elemental formula C18H14N4O4S3
was the best ﬁt for this impurity. This elemental for-
mula, along with MS/MS analysis of MS447 (see Figure 8),
supported a thioether linked dimer of benzothiazole as
the structure for MS447 (see Table 6). This symmetrical
thioether compound could participate in the same reaction
as AMG 517 step 2 to generate Unknown 2 (see Figure 9).
An accurate mass of 405.0144Da was determined for the
protonated ion of impurity MS405. Elemental composition
analysis using the observed mass determined that the
elemental formula C16H12N4O3S3 was the best ﬁt for the
impurity. MS405 was proposed to be the mono-deacetylated
form of MS447.12 International Journal of Analytical Chemistry
Accurate mass determination for each of the three
peaks designated MS415 led to the assignment of exact
mass values that were in close agreement with each other
(415.0522Da, 415.0540Da, and 415.0536Da, in order of
elution), and elemental composition analysis using these
observed mass values points to the same elemental compo-
sition (C18H14N4O4S2) as the most likely formula for each.
These three MS415 impurities in N-acetyl benzothiazole
could be positional isomers to each other. One of these
isomers, a symmetrical ortho dimer (see Table 6), was a
plausible precursor for the proposed structure of Unknown
1 (see Figure 9).
Accurate mass determination for each of the two peaks
designated MS287 led to the assignment of exact mass values
thatareinclose agreementwith eachother(286.9486Daand
286.9475Da,inorderofelution),andelementalcomposition
analysis using these observed mass values points to the
same elemental composition (C9H7N2O2SBr) as the most
likely formula for each. Structures consistent with these
elemental formulae are shown in Table 6.T h ep r e s e n c eo f
these molecules in the benzothiazole synthetic process could
lead to the formation of impurities MS415 and MS447.
4. Conclusion
An extensive investigation successfully utilized multiple
analytical disciplines to elucidate structures for two complex
impurities in AMG 517 drug substance and to trace the
source of the impurities to a starting material used in the
manufacture of AMG 517.
The structures of two unknown impurities in AMG 517
drug substance were identiﬁed through extensive HPLC, LC-
MS, high resolution MS, MS/MS, and 1D and 2D NMR
studies. The existence of an unexpected C-S-C linkage in
one of the impurities was conﬁrmed. Further investigation
revealed that these impurities originated from existing
impurities in the N-acetyl benzothiazole starting material
used in AMG 517 synthesis. This information was shared
with the supplier of this starting material, and the process for
N-acetyl benzothiazole preparation was re-evaluated. Better
synthetic process controls and tighter speciﬁcations were
establishedresultinginhigherqualityN-acetylbenzothiazole
batches. These two dimeric impurities were not observed in
subsequent larger-scale AMG 517 production runs.
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